GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CTT Pharmaceutical Holdings Inc (OTCPK:CTTH) » Definitions » Debt-to-Revenue

CTT Pharmaceutical Holdings (CTT Pharmaceutical Holdings) Debt-to-Revenue : N/A (As of Jun. 2018)


View and export this data going back to . Start your Free Trial

What is CTT Pharmaceutical Holdings Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

CTT Pharmaceutical Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2018 was $0.00 Mil. CTT Pharmaceutical Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2018 was $0.04 Mil. CTT Pharmaceutical Holdings's annualized Revenue for the quarter that ended in Jun. 2018 was $0.00 Mil.


CTT Pharmaceutical Holdings Debt-to-Revenue Historical Data

The historical data trend for CTT Pharmaceutical Holdings's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CTT Pharmaceutical Holdings Debt-to-Revenue Chart

CTT Pharmaceutical Holdings Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only N/A N/A N/A N/A N/A

CTT Pharmaceutical Holdings Quarterly Data
Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Mar17 Jun17 Mar18 Jun18
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A - N/A N/A N/A

Competitive Comparison of CTT Pharmaceutical Holdings's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, CTT Pharmaceutical Holdings's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CTT Pharmaceutical Holdings's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CTT Pharmaceutical Holdings's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where CTT Pharmaceutical Holdings's Debt-to-Revenue falls into.



CTT Pharmaceutical Holdings Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

CTT Pharmaceutical Holdings's Debt-to-Revenue for the fiscal year that ended in Dec. 2015 is calculated as

CTT Pharmaceutical Holdings's annualized Debt-to-Revenue for the quarter that ended in Jun. 2018 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Jun. 2018) Revenue data.


CTT Pharmaceutical Holdings Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of CTT Pharmaceutical Holdings's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


CTT Pharmaceutical Holdings (CTT Pharmaceutical Holdings) Business Description

Traded in Other Exchanges
N/A
Address
1100 – 1111 Melville Street, Vancouver, BC, CAN, V6E 3V6
CTT Pharmaceutical Holdings Inc is a development stage company specializing in drug delivery systems technology within the pharmaceutical industry. It focuses on fast-dissolving drug delivery systems through the development of oral delivery thin wafers. The thin wafers are infused with both natural and synthetic cannabis extracts to deliver treatment as an alternative to smoking and ingestion. Its products include Medwafe, Cannawafe, Vetwafe, and others.
Executives
Albert C Zapanta director PO BOX 2020, SPRINGDALE AR 72765
William Thomson director 390 BAY ST, SUITE 1102, TORONTO ONTARIO A6 M5H 2Y2

CTT Pharmaceutical Holdings (CTT Pharmaceutical Holdings) Headlines